发明名称 ZNF532 FOR DIAGNOSIS AND TREATMENT OF CANCER
摘要 The present invention relates to the use of ZNF532 inhibitors for the treatment of cancer, in particular cancer with cells that express the ZNF532 protein or harbor the ZNF532-NUT fusion gene. In some embodiments, the cancer is selected from the group consisting of NUT midline carcinoma (NMC), Ewing sarcoma, and head and neck squamous cell carcinoma.
申请公布号 WO2016179222(A1) 申请公布日期 2016.11.10
申请号 WO2016US30674 申请日期 2016.05.04
申请人 THE BRIGHAM AND WOMEN'S HOSPITAL, INC. 发明人 FRENCH, Christopher Alexander;KURODA, Mitzi I.;WALSH, Erica M.;ALEKSEYENKO, Artyom A.
分类号 A61K39/00;A61K31/55;C12N15/11;C12Q1/68;G01N33/53 主分类号 A61K39/00
代理机构 代理人
主权项
地址